The path is clear
Individuals considering weight management medications should consult a qualified healthcare professional before starting or modifying any treatment plan.
A 2019 review in Nutrients examining NAD+ precursor safety in human clinical trials found oral NMN and NR well-tolerated at doses up to 1,000 mg/day with no serious adverse events reported
5mg vial dose charts 5mg vial + 1mL bacteriostatic water = 5mg/mL At this concentration, a 5mg vial gives you five weeks of coverage at the 1mg initiation dose, or just over two weeks at 2mg
Safety and tolerability outcomes comprised discontinuation of treatment due to adverse events, incidence of serious adverse events, all-cause mortality, hypoglycaemia (plasma glucose 3.9 mmol/l), severe hypoglycaemia (a hypoglycaemic event requiring assistance), nausea, vomiting and diarrhoea
Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, et al